ClinOne Creates World’s First Proactive Clinical Trial Patient Engagement Monitoring
DENVER, Jan. 31, 2018 /PRNewswire/ — ClinOne, a mobile clinical trial management solution, is revolutionizing how patients manage the complexities of a clinical trial, navigate appointments, and manage their research documents with the first proactive patient engagement monitoring technology of its kind.
Clinical trial sponsors have long awaited a technology that allows real-time measurement and visualization of engagement of each of their participants and also benchmark engagement data across all their study sites prior to patient withdrawing from a study.
“Through ClinOne’s analytical engine, we can measure a patient’s engagement level and report this information back to the site daily, weekly and monthly through our digital concierge. Sites utilize the information to alter and improve their patient experience – and can even intervene if a patient needs additional support and care during their clinical trial participation,” said Rob Bohacs, CEO of ClinOne.
Research institutions and clinical trial sponsors are seeking solutions to provide improved patient care during clinical trial participation and decrease patient dropout/withdrawal. ClinOne’s suite of technology solutions includes a digital concierge that provides patients with a technology suite to assist the clinical trial lifecycle. Every research institution receives continuous feedback from the ClinOne technology on the level of each patient’s compliance and engagement. The system proactively alerts site coordinators if certain patients fall below engagement targets.
The ClinOne solution and its suite of products were created to improve clinical trial enrollment, retention and research site compliance. The company’s sole mission is to allow important trial details to be at the fingertips of participating researchers and patients. Currently, more than 2,500 active clinical trials in 48 countries rely on ClinOne’s suite of technologies. Visit www.clinone.com for more information.
SOURCE ClinOne, Inc.